These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29909141)

  • 1. New-onset diabetes after androgen-deprivation therapy for prostate cancer: A nationwide propensity score-matched four-year longitudinal cohort study.
    Jhan JH; Yeh HC; Chang YH; Guu SJ; Wu WJ; Chou YH; Li CC
    J Diabetes Complications; 2018 Jul; 32(7):688-692. PubMed ID: 29909141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of developing hypertension after hormone therapy for prostate cancer: a nationwide propensity score-matched longitudinal cohort study.
    Wu YH; Jhan JH; Ke HL; Tseng SI; Chang YH; Yeh HC; Li CC; Lee YC
    Int J Clin Pharm; 2020 Dec; 42(6):1433-1439. PubMed ID: 32951178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer.
    Crawley D; Garmo H; Rudman S; Stattin P; Häggström C; Zethelius B; Holmberg L; Adolfsson J; Van Hemelrijck M
    Int J Cancer; 2016 Dec; 139(12):2698-2704. PubMed ID: 27557616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy for prostate cancer increases the risk of Alzheimer's disease: a nationwide 4-year longitudinal cohort study.
    Jhan JH; Yang YH; Chang YH; Guu SJ; Tsai CC
    Aging Male; 2017 Mar; 20(1):33-38. PubMed ID: 28067607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between ischaemic bowel syndromes and androgen deprivation therapy in patients with prostate cancer: a retrospective cohort study.
    Chiang IN; Huang CY; Pu YS; Chang CH; Muo CH; Chung CJ; Wang RY; Young TH
    BMJ Open; 2017 Feb; 7(2):e012950. PubMed ID: 28246133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen Deprivation Therapy and the Risk of Dementia after Treatment for Prostate Cancer.
    Lonergan PE; Washington SL; Cowan JE; Zhao S; Broering JM; Cooperberg MR; Carroll PR
    J Urol; 2022 Apr; 207(4):832-840. PubMed ID: 34854749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer.
    Young JWS; Sutradhar R; Rangrej J; Marras C; Fleshner N; Alibhai SMH
    World J Urol; 2017 Sep; 35(9):1417-1423. PubMed ID: 28204918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen deprivation therapy did not increase the risk of Alzheimer's and Parkinson's disease in patients with prostate cancer.
    Chung SD; Lin HC; Tsai MC; Kao LT; Huang CY; Chen KC
    Andrology; 2016 May; 4(3):481-5. PubMed ID: 27062333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer: a 5-year follow-up study.
    Kao LT; Lin HC; Chung SD; Huang CY
    Asian J Androl; 2017; 19(4):414-417. PubMed ID: 27232853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of Major Long-Term Side Effects Associated with Androgen-Deprivation Therapy in Men with Prostate Cancer.
    Nguyen C; Lairson DR; Swartz MD; Du XL
    Pharmacotherapy; 2018 Oct; 38(10):999-1009. PubMed ID: 30080934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer.
    Ziehr DR; Chen MH; Zhang D; Braccioforte MH; Moran BJ; Mahal BA; Hyatt AS; Basaria SS; Beard CJ; Beckman JA; Choueiri TK; D'Amico AV; Hoffman KE; Hu JC; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    BJU Int; 2015 Sep; 116(3):358-65. PubMed ID: 25124891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer.
    Liu JM; Chen TH; Chuang HC; Wu CT; Hsu RJ
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):276-283. PubMed ID: 30337635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen deprivation therapy and the risk of iron-deficiency anaemia among patients with prostate cancer: a population-based cohort study.
    Wu FJ; Li IH; Chien WC; Shih JH; Lin YC; Chuang CM; Cheng YD; Kao LT
    BMJ Open; 2020 Mar; 10(3):e034202. PubMed ID: 32213519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is androgen deprivation therapy associated with cerebral infarction in patients with prostate cancer? A Korean nationwide population-based propensity score matching study.
    Tae BS; Jeon BJ; Choi H; Bae JH; Park JY
    Cancer Med; 2019 Aug; 8(9):4475-4483. PubMed ID: 31183968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of androgen-deprivation therapy and radiotherapy for older men with locally advanced prostate cancer.
    Bekelman JE; Mitra N; Handorf EA; Uzzo RG; Hahn SA; Polsky D; Armstrong K
    J Clin Oncol; 2015 Mar; 33(7):716-22. PubMed ID: 25559808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective cohort study of androgen deprivation therapy and the risk of diabetes in men with prostate cancer in Lithuania.
    Drevinskaite M; Patasius A; Kincius M; Urbonas V; Smailyte G
    BMJ Open; 2021 Jul; 11(7):e045797. PubMed ID: 34321292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined androgen blockade achieved better oncological outcome in androgen deprivation therapy for prostate cancer: Analysis of community-based multi-institutional database across Japan using propensity score matching.
    Onozawa M; Akaza H; Hinotsu S; Oya M; Ogawa O; Kitamura T; Suzuki K; Naito S; Namiki M; Nishimura K; Hirao Y; Tsukamoto T
    Cancer Med; 2018 Oct; 7(10):4893-4902. PubMed ID: 30151999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between androgen-deprivation therapy and incidence of diabetes among males with prostate cancer.
    Lage MJ; Barber BL; Markus RA
    Urology; 2007 Dec; 70(6):1104-8. PubMed ID: 18158027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No increased risk of coronary heart disease for patients receiving androgen deprivation therapy for prostate cancer in Chinese/Taiwanese men.
    Wang LH; Liu CK; Chen CH; Kao LT; Lin HC; Huang CY
    Andrology; 2016 Jan; 4(1):128-32. PubMed ID: 26711703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.
    Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D
    Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.